EYPT - EyePoint Pharmaceuticals Inc. (EYPT) CEO Nancy Lurker on Q4 2021 Results - Earnings Call Transcript

EyePoint Pharmaceuticals, Inc. (EYPT Q4 2021 Earnings Conference Call March 3, 2022, 08:30 AM ET Company Participants George Elston - CFO Nancy Lurker - President & CEO Jay Duker - COO Scott Jones - Chief Commercial Officer Conference Call Participants Jennifer Kim - Cantor Fitzgerald Georgi Yordanov - Cowen Eddie Hickman - Guggenheim Securities Yi Chen - H.C. Wainwright Yale Jen - Laidlaw & Company Presentation Operator Good morning. My name is Jonathan. And I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Development's conference call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to George Elston, Chief Financial

For further details see:

EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q4 2021 Results - Earnings Call Transcript